The COAPT trial investigated the use of the MitraClip a novel device for patients with secondary mitral regurgitation, a condition in which blood leaks backward through the mitral valve into the left atrium of the heart. In this touchCARDIO interview Dr Gregg Stone (Mount Sinai Heart Health System, New York City, NY, USA) discusses the implications of the COAPT trial results, the significance of these findings, their potential impact on clinical practice, and what they mean for patients with secondary mitral regurgitation.
The abstract entitled ‘Transcatheter Edge-to-edge Repair Of Functional Mitral Regurgitation In Heart Failure: Final Five-year Results From The COAPT Trial‘ (Abstract number 405-12) was presented at ACC.23 Together With WCC (ACC.23/WCC) in New Orleans, 4–6 March 2023.
- What were the aims, design and eligibility criteria of the COAPT trial? (0:15)
- What were the primary and secondary endpoints, and what were the key findings of the COAPT trial? (1:58)
- What implications do the long-term outcomes of the COAPT trial have for the use of mitral transcatheter edge-to-edge repair as a treatment option for functional mitral regurgitation (MR) in heart failure (HF) patients? (3:11)
- Looking ahead, what further research is needed to fully understand the role of transcatheter edge-to-edge repair in the management of functional MR in HF patients? (4:12)
Disclosures: Gregg Stone has received grant/research support from Abbott, and honoraria/honorarium from Abbott.
Support: Interview and filming supported by Touch Medical Media. Interview conducted by Katey Gabrysch.
Filmed as a highlight of ACC 2023
Share this Video
Related Videos In Interventional Cardiology
Gregg Stone, ACC 2023: Transcatheter edge-to-edge repair for functional mitral regurgitation in heart failure
Transcatheter edge-to-edge repair (TEER) is a minimally invasive procedure that can effectively treat functional mitral regurgitation in heart failure patients. Compared to traditional surgical approaches, TEER offers benefits such as reduced hospital stay, lower risk of bleeding and infection, and faster recovery time. Additionally, TEER has been found to improve symptoms and quality of life […]
Gregg Stone, ACC 2023: COAPT trial results – Transcatheter edge-to-edge repair with MitraClip device for functional mitral regurgitation in heart failure
The COAPT trial investigated the use of the MitraClip a novel device for patients with secondary mitral regurgitation, a condition in which blood leaks backward through the mitral valve into the left atrium of the heart. In this touchCARDIO interview Dr Gregg Stone (Mount Sinai Heart Health System, New York City, NY, USA) discusses the […]
Hyo-Soo Kim, ACC 2023: Guidelines for the use of short-term dual antiplatelet therapy after coronary intervention
The guidelines for the use of short-term dual antiplatelet therapy (DAPT) after coronary intervention vary depending on the patient’s clinical situation and the type of intervention performed. In this touchCARDIO interview, we speak with Prof. Hyo-Soo Kim (Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea) to discuss the current guidelines for the […]
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!